The EFSUMB guidelines and recommendations on the clinical practice of contrast enhanced ultrasound (CEUS): Update 2011 on non-hepatic applications

Ultraschall in der Medizin

Volumn 33, Issue 1, 2012, Pages 33-59

  Piscaglia, F ^a   Nolsoe C ^b   Dietrich, C F ^c   Cosgrove, D O ^d   Gilja, O H ^e,f   Bachmann Nielsen, M ^g   Albrecht, T ^h   Barozzi, L ^a   Bertolotto, M ⁱ   Catalano, O ^j   Claudon, M ^k   Clevert, D A ^l   Correas, J M ^m   Donofrio, M ⁿ   Drudi, F M ^o   Eyding, J ^p   Giovannini, M ^q   Hocke, M ^r   Ignee, A ^c   Jung, E M ^s   Klauser, A S ^t   Lassau, N ^u   Leen, E ^d   Mathis, G ^v   Saftoiu, A ^w   Seidel, G ^x   Sidhu, P S ^y   Haar, G Ter ^z   Timmerman, D ^aa   Weskott, H P ^ab   more..

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c CARITAS KRANKENHAUS   (Germany)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^f UNIVERSITY OF BERGEN   (Norway)

^g International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^h VIVANTES KLINIKUM NEUKÖLLN   (Germany)

ⁱ UNIVERSITY OF TRIESTE   (Italy)

^j NATIONAL CANCER INSTITUTE   (Italy)

^k HÔPITAL D ENFANTS   (France)

^l LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^m UNIVERSITÉ PARIS DESCARTES   (France)

ⁿ UNIVERSITY OF VERONA   (Italy)

^o SAPIENZA UNIVERSITY OF ROME   (Italy)

^p ST JOSEF HOSPITAL   (Germany)

^q INSTITUT PAOLI CALMETTES   (France)

^r Klinikum Meiningen   (Germany)

^s UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^t INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^u INSTITUT GUSTAVE ROUSSY   (France)

^v Internal Medicine   (Austria)

^w UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

^x Asklepios Klinik Nord Heidberg   (Germany)

^y KING S COLLEGE HOSPITAL   (United Kingdom)

^z ROYAL MARSDEN HOSPITAL   (United Kingdom)

^aa UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^ab Krankenhaus Siloah   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMINOID; CONTRAST AGENT BR1; CONTRAST MEDIUM; DIAGNOSTIC AGENT; FLUOROCARBON; PERFLUTREN; PHOSPHOLIPID; POLYSACCHARIDE; SHU 508; SULFUR HEXAFLUORIDE;

ADULT; CHILD; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; DOPPLER FLOWMETRY; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; FEMALE; HUMAN; IMAGE ENHANCEMENT; LIVER; MALE; METHODOLOGY; PRACTICE GUIDELINE; SENSITIVITY AND SPECIFICITY;

ADULT; ALBUMINS; CHILD; CONTRAST MEDIA; ENDOSONOGRAPHY; FEMALE; FLUOROCARBONS; HUMANS; IMAGE ENHANCEMENT; LIVER; MALE; PHOSPHOLIPIDS; POLYSACCHARIDES; SENSITIVITY AND SPECIFICITY; SULFUR HEXAFLUORIDE; ULTRASONOGRAPHY; ULTRASONOGRAPHY, DOPPLER;

EID: 84857062533     PISSN: 01724614     EISSN: 14388782     Source Type: Journal    
DOI: 10.1055/s-0031-1281676     Document Type: Article

References (282)

1. Bertolotto M, Dalla P alma L, Quaia E et al. Characterization of unifocal liver lesions with pulse inversion harmonic imaging after Levovist injection: preliminary results. Eur Radiol 2000 10 1369-1376
2. Burns P N., Wilson S R., Simpson D H. Pulse inversion imaging of liver blood flow: improved method for characterizing focal masses with microbubble contrast. Invest Radiol 2000 35 58-71 (Pubitemid 30033608)
3. Albrecht T, Blomley M, Bolondi L et al. Guidelines for the use of contrast agents in ultrasound. January 2004. Ultraschall in Med 2004 25 249-256 (Pubitemid 39128145)
4. Claudon M, Cosgrove D, Albrecht T et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - update 2008. Ultraschall in Med 2008 29 28-44 (Pubitemid 351294171)
5. Nolsoe C, Piscaglia F, Dietrich C F. et al. Reply to M. Piskunowicz, W. Kosiak and N. Irgas Letter to the Editor entitled Primum non nocere? Why Cant We Use Second Generation Ultrasound Contrast Agents for the Examination of Children?. Ultraschall in Med 2011 32 83-86
6. Averkiou M, Powers J, Skyba D et al. Ultrasound contrast imaging research. Ultrasound Q 2003 19 27-37 (Pubitemid 36547040)
7. Schrope B A., Newhouse V L. Second harmonic ultrasonic blood perfusion measurement. Ultrasound Med Biol 1993 19 567-579 (Pubitemid 23315933)
8. Simpson D H., Chin C T., Burns P N. Pulse inversion Doppler: a new method for detecting nonlinear echoes from microbubble contrast agents. IEEE Trans Ultrason Ferroelectr Freq Control 1999 46 372-382
9. Burns P, Powers J, Hope Simpson D et al. Harmonic Imaging: principals and preliminary results. Angiology 1996 47 SA63-SA74
10. Dietrich C F., Ignee A, Hocke M et al. Pitfalls and artefacts using contrast enhanced ultrasound. Z Gastroenterol 2011 49 350-356
11. Minimum training recommendations for the practice of medical ultrasound. Ultraschall in Med 2006 27 79-105
12. Minimum training requirements for the practice of Medical Ultrasound in Europe. Ultraschall in Med 2010 31 426-427
13. Gilja O H. Report Education and Professional Standard Commitee. In EFSUMB Newsletter. Ultraschall in Med 2009 30 86-87
14. Lassau N, Chami L, Benatsou B et al. Dynamic contrast-enhanced ultrasonography (DCE-US) with quantification of tumor perfusion: a new diagnostic tool to evaluate the early effects of antiangiogenic treatment. Eur Radiol 2007 17 (Suppl 6) F89-F98 (Pubitemid 351337913)
15. Piscaglia F, Bolondi L. The safety of Sonovue in abdominal applications: retrospective analysis of 23 188 investigations. Ultrasound Med Biol 2006 32 1369-1375 (Pubitemid 44332662)
16. ter Haar G. Safety and bio-effects of ultrasound contrast agents. Med Biol Eng Comput 2009 47 893-900
17. Blomley M, Claudon M, Cosgrove D. WFUMB Safety Symposium on Ultrasound Contrast Agents: clinical applications and safety concerns. Ultrasound Med Biol 2007 33 180-186 (Pubitemid 46240590)
18. Barnett S B. Safe use of ultrasound contrast agents. Ultrasound Med Biol 2007 33 171-172 (Pubitemid 46240584)
19. Main M L., Goldman J H., Grayburn P A. Ultrasound contrast agents: balancing safety versus efficacy. Expert Opin Drug Saf 2009 8 49-56
20. Main M L., Ryan A C., Davis T E. et al. Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent (multicenter registry results in 4,300,966 consecutive patients). Am J Cardiol 2008 102 1742-1746
21. Dietrich C F., Braden B, Hocke M et al. Improved characterisation of solitary solid pancreatic tumours using contrast enhanced transabdominal ultrasound. J Cancer Res Clin Oncol 2008 134 635-643
22. DOnofrio M, Megibow A J., Faccioli N et al. Comparison of contrast-enhanced sonography and MRI in displaying anatomic features of cystic pancreatic masses. Am J Roentgenol 2007 189 1435-1442 (Pubitemid 350174806)
23. Kitano M, Kudo M, Maekawa K et al. Dynamic imaging of pancreatic diseases by contrast enhanced coded phase inversion harmonic ultrasonography. Gut 2004 53 854-859 (Pubitemid 38662136)
24. DOnofrio M, Malago R, Zamboni G et al. Contrast-enhanced ultrasonography better identifies pancreatic tumor vascularization than helical CT. Pancreatology 2005 5 398-402 (Pubitemid 41160277)
25. Faccioli N, DOnofrio M, Malago R et al. Resectable pancreatic adenocarcinoma: depiction of tumoral margins at contrast-enhanced ultrasonography. Pancreas 2008 37 265-268
26. Grossjohann H S., Rappeport E D., Jensen C et al. Usefulness of contrast-enhanced transabdominal ultrasound for tumor classification and tumor staging in the pancreatic head. Scand J Gastroenterol 2010 45 917-924
27. DOnofrio M, Zamboni G, Tognolini A et al. Mass-forming pancreatitis: value of contrast-enhanced ultrasonography. World J Gastroenterol 2006 12 4181-4184 (Pubitemid 44376898)
28. Kersting S, Konopke R, Kersting F et al. Quantitative perfusion analysis of transabdominal contrast-enhanced ultrasonography of pancreatic masses and carcinomas. Gastroenterology 2009 137 1903-1911
29. Numata K, Ozawa Y, Kobayashi N et al. Contrast-enhanced sonography of pancreatic carcinoma: correlations with pathological findings. J Gastroenterol 2005 40 631-640 (Pubitemid 41038793)
30. DOnofrio M, Barbi E, Dietrich C F. Pancreatic multicenter ultrasound study (PAMUS). Eur J Radiol 2011 e-pub
31. Tawada K, Yamaguchi T, Kobayashi A et al. Changes in tumor vascularity depicted by contrast-enhanced ultrasonography as a predictor of chemotherapeutic effect in patients with unresectable pancreatic cancer. Pancreas 2009 38 30-35
32. Kobayashi A, Yamaguchi T, Ishihara T et al. Evaluation of vascular signal in pancreatic ductal carcinoma using contrast enhanced ultrasonography: effect of systemic chemotherapy. Gut 2005 54 1047 (Pubitemid 40873925)
33. DOnofrio M, Mansueto G, Falconi M et al. Neuroendocrine pancreatic tumor: value of contrast enhanced ultrasonography. Abdom Imaging 2004 29 246-258 (Pubitemid 38365018)
34. Malago R, DOnofrio M, Zamboni G A. et al. Contrast-enhanced sonography of nonfunctioning pancreatic neuroendocrine tumors. Am J Roentgenol 2009 192 424-430
35. Rickes S, Wermke W. Differentiation of cystic pancreatic neoplasms and pseudocysts by conventional and echo-enhanced ultrasound. J Gastroenterol Hepatol 2004 19 761-766 (Pubitemid 38981397)
36. Itoh T, Hirooka Y, Itoh A et al. Usefulness of contrast-enhanced transabdominal ultrasonography in the diagnosis of intraductal papillary mucinous tumors of the pancreas. Am J Gastroenterol 2005 100 144-152 (Pubitemid 41623282)
37. Dietrich C F., Ignee A, Braden B et al. Improved differentiation of pancreatic tumors using contrast-enhanced endoscopic ultrasound. Clin Gastroenterol Hepatol 2008 6 590-597, e591
38. DOnofrio M, Gallotti A, Pozzi Mucelli R. Imaging techniques in pancreatic tumors. Expert Rev Med Devices 2010 7 257-273
39. Ripolles T, Martinez M J., Lopez E et al. Contrast-enhanced ultrasound in the staging of acute pancreatitis. Eur Radiol 2010 20 2518-2523
40. Becker D, Strobel D, Bernatik T et al. Echo-enhanced color- and power-Doppler EUS for the discrimination between focal pancreatitis and pancreatic carcinoma. Gastrointest Endosc 2001 53 784-789 (Pubitemid 33717254)
41. Bhutani M S., Hoffman B J., Velse A van et al. Contrast-enhanced endoscopic ultrasonography with galactose microparticles: SHU508 A (Levovist). Endoscopy 1997 29 635-639 (Pubitemid 27472605)
42. Dietrich C F., Ignee A, Frey H. Contrast-enhanced endoscopic ultrasound with low mechanical index: a new technique. Z Gastroenterol 2005 43 1219-1223 (Pubitemid 41719249)
43. Dietrich C F. Contrast-enhanced low mechanical index endoscopic ultrasound (CELMI-EUS). Endoscopy 2009 41 (Suppl 2) E43-E44
44. Kitano M, Sakamoto H, Matsui U et al. A novel perfusion imaging technique of the pancreas: contrast-enhanced harmonic EUS (with video). Gastrointest Endosc 2008 67 141-150 (Pubitemid 350278602)
45. Hocke M, Schmidt C, Zimmer B et al. [Contrast enhanced endosonography for improving differential diagnosis between chronic pancreatitis and pancreatic cancer]. Dtsch Med Wochenschr 2008 133 1888-1892
46. Hocke M, Schulze E, Gottschalk P et al. Contrast-enhanced endoscopic ultrasound in discrimination between focal pancreatitis and pancreatic cancer. World J Gastroenterol 2006 12 246-250 (Pubitemid 43336923)
47. Kitano M, Takagi T, Sakamoto H. Dynamic imaging of pancreatic tumors by contrast-enhanced harmonic EUS with long-lasting contrast. Gastrointestinal Endoscopy 2009 67 141-150 (Pubitemid 350278602)
48. Sakamoto H, Kitano M, Kamata K et al. Diagnosis of pancreatic tumors by endoscopic ultrasonography. World J Radiol 2010 2 122-134
49. Hirooka Y, Itoh A, Kawashima H et al. Diagnosis of pancreatic disorders using contrast-enhanced endoscopic ultrasonography and endoscopic elastography. Clin Gastroenterol Hepatol 2009 7 S63-S67
50. Saftoiu A, Iordache S A., Gheonea D I. et al. Combined contrast-enhanced power Doppler and real-time sonoelastography performed during EUS, used in the differential diagnosis of focal pancreatic masses (with videos). Gastrointest Endosc 2010 72 739-747
51. Giovannini M. Contrast-enhanced endoscopic ultrasound and elastosonoendoscopy. Best Pract Res Clin Gastroenterol 2009 23 767-779
52. Hocke M, Ignee A, Topalidis T et al. Contrast-enhanced endosonographic Doppler spectrum analysis is helpful in discrimination between focal chronic pancreatitis and pancreatic cancer. Pancreas 2007 35 286-288 (Pubitemid 47482526)
53. Napoleon B, Alvarez-Sanchez M V., Gincoul R et al. Contrast-enhanced harmonic endoscopic ultrasound in solid lesions of the pancreas: results of a pilot study. Endoscopy 2010 42 564-570
54. Seicean A, Badea R, Stan-Iuga R et al. The added value of real-time harmonics contrast-enhanced endoscopic ultrasonography for the characterisation of pancreatic diseases in routine practice. J Gastrointestin Liver Dis 2010 19 99-104
55. Seicean A, Badea R, Stan-Iuga R et al. Quantitative contrast-enhanced harmonic endoscopic ultrasonography for the discrimination of solid pancreatic masses. Ultraschall in Med 2010 31 571-576
56. Fusaroli P, Spada A, Mancino M G. et al. Contrast harmonic echo-endoscopic ultrasound improves accuracy in diagnosis of solid pancreatic masses. Clin Gastroenterol Hepatol 2010 8 629-634, e621 e622
57. Beyer-Enke S A., Hocke M, Ignee A et al. Contrast enhanced transabdominal ultrasound in the characterisation of pancreatic lesions with cystic appearance. JOP 2010 11 427-433
58. Hocke M, Ignee A, Dietrich C F. Contrast-enhanced endoscopic ultrasound in the diagnosis of autoimmune pancreatitis. Endoscopy 2011 43 163-165
59. Plikat K, Klebl F, Buchner C et al. [Evaluation of intestinal hyperaemia in inflamed bowel by high resolution Contrast Harmonic Imaging (CHI)]. Ultraschall in Med 2004 25 257-262 (Pubitemid 39128146)
60. Girlich C, Jung E M., Iesalnieks I et al. Quantitative assessment of bowel wall vascularisation in Crohns disease with contrast-enhanced ultrasound and perfusion analysis. Clin Hemorheol Microcirc 2009 43 141-148
61. Schlottmann K, Kratzer W, Scholmerich J. Doppler ultrasound and intravenous contrast agents in gastrointestinal tract disorders: current role and future implications. Eur J Gastroenterol Hepatol 2005 17 263-275 (Pubitemid 40411211)
62. Schreyer A G., Finkenzeller T, Gossmann H et al. Microcirculation and perfusion with contrast enhanced ultrasound (CEUS) in Crohns disease: first results with linear contrast harmonic imaging (CHI). Clin Hemorheol Microcirc 2008 40 143-155
63. Pauls S, Gabelmann A, Schmidt S A. et al. Evaluating bowel wall vascularity in Crohns disease: a comparison of dynamic MRI and wideband harmonic imaging contrast-enhanced low MI ultrasound. Eur Radiol 2006 16 2410-2417 (Pubitemid 44649690)
64. Haber H P., Busch A, Ziebach R et al. Bowel wall thickness measured by ultrasound as a marker of Crohns disease activity in children. Lancet 2000 355 1239-1240 (Pubitemid 30184535)
65. Maconi G, Parente F, Bollani S et al. Abdominal ultrasound in the assessment of extent and activity of Crohns disease: clinical significance and implication of bowel wall thickening. Am J Gastroenterol 1996 91 1604-1609 (Pubitemid 26269179)
66. Spalinger J, Patriquin H, Miron M C. et al. Doppler US in patients with crohn disease: vessel density in the diseased bowel reflects disease activity. Radiology 2000 217 787-791
67. Robotti D, Cammarota T, Debani P et al. Activity of Crohn disease: value of Color-Power-Doppler and contrast-enhanced ultrasonography. Abdom Imaging 2004 29 648-652 (Pubitemid 39331696)
68. De Pascale A, Garofalo G, Perna M et al. Contrast-enhanced ultrasonography in Crohns disease. Radiol Med 2006 111 539-550
69. Serra C, Menozzi G, Labate A M. et al. Ultrasound assessment of vascularization of the thickened terminal ileum wall in Crohns disease patients using a low-mechanical index real-time scanning technique with a second generation ultrasound contrast agent. Eur J Radiol 2007 62 114-121 (Pubitemid 46413629)
70. Migaleddu V, Scanu A M., Quaia E et al. Contrast-enhanced ultrasonographic evaluation of inflammatory activity in Crohns disease. Gastroenterology 2009 137 43-52
71. Girlich C, Schacherer D, Jung E M. et al. Comparison between a clinical activity index (Harvey-Bradshaw-Index), laboratory inflammation markers and quantitative assessment of bowel wall vascularization by contrast-enhanced ultrasound in Crohns disease. Eur J Radiol 2011 epub
72. Ripolles T, Martinez M J., Paredes J M. et al. Crohn disease: correlation of findings at contrast-enhanced US with severity at endoscopy. Radiology 2009 253 241-248
73. Guidi L, De Franco A, De Vitis I et al. Contrast-enhanced ultrasonography with SonoVue after infliximab therapy in Crohns disease. Eur Rev Med Pharmacol Sci 2006 10 23-26
74. Kratzer W, Tirpitz C von, Mason R et al. Contrast-enhanced power Doppler sonography of the intestinal wall in the differentiation of hypervascularized and hypovascularized intestinal obstructions in patients with Crohns disease. J Ultrasound Med 2002 21 149-157, quiz 158 149 (Pubitemid 34127318)
75. Wilson S R., Burns P N. Microbubble-enhanced US in body imaging: what role? Radiology 2010 257 24-39
76. Girlich C, Schacherer D, Lamby P et al. Innovations in contrast enhanced high resolution ultrasound improve sonographic imaging of the intestine. Clin Hemorheol Microcirc 2010 45 207-215
77. Henrich W, Meckies J, Friedmann W. Demonstration of a recto-vaginal fistula with the ultrasound contrast medium Echovist. Ultrasound Obstet Gynecol 2000 15 148-149 (Pubitemid 33108736)
78. Dietrich C F. Significance of abdominal ultrasound in inflammatory bowel disease. Dig Dis 2009 27 482-493
79. Gorg C, Bert T. Contrast enhanced sonography of focal splenic lesions with a second-generation contrast agent. Ultraschall in Med 2005 26 470-477 (Pubitemid 43041340)
80. Cavalli G, Re G, Casali A M. Red pulp arterial terminals in congestive splenomegaly. A morphometric study. Pathol Res Pract 1984 178 590-594 (Pubitemid 14030284)
81. Lim A K., Patel N, Eckersley R J. et al. Evidence for spleen-specific uptake of a microbubble contrast agent: a quantitative study in healthy volunteers. Radiology 2004 231 785-788 (Pubitemid 38668098)
82. Bertolotto M, Quaia E, Zappetti R et al. Differential diagnosis between splenic nodules and peritoneal metastases with contrast-enhanced ultrasound based on signal-intensity characteristics during the late phase. Radiol Med 2009 114 42-51
83. Gorg C, Bert T. Second-generation sonographic contrast agent for differential diagnosis of perisplenic lesions. Am J Roentgenol 2006 186 621-626 (Pubitemid 46100247)
84. Gorg C, Graef C, Bert T. Contrast-enhanced sonography for differential diagnosis of an inhomogeneous spleen of unknown cause in patients with pain in the left upper quadrant. J Ultrasound Med 2006 25 729-734 (Pubitemid 43830462)
85. Liu G J., Lu M D., Xie X Y. et al. Real-time contrast-enhanced ultrasound imaging of infected focal liver lesions. J Ultrasound Med 2008 27 657-666
86. Chiavaroli R, Grima P, Tundo P. Characterization of nontraumatic focal splenic lesions using contrast-enhanced sonography. J Clin Ultrasound 2011 39 310-315
87. Catalano O, Sandomenico F, Matarazzo I et al. Contrast-enhanced sonography of the spleen. Am J Roentgenol 2005 184 1150-1156 (Pubitemid 43821889)
88. Gorg C, Faoro C, Bert T et al. Contrast enhanced ultrasound of splenic lymphoma involvement. Eur J Radiol 2009 epub
89. Sutherland T, Temple F, Hennessy O et al. Contrast-enhanced ultrasound features of primary splenic lymphoma. J Clin Ultrasound 2010 38 317-319
90. Yu X, Yu J, Liang P et al. Real-time contrast-enhanced ultrasound in diagnosing of focal spleen lesions. Eur J Radiol 2011 epub
91. Herbay A von, Barreiros A P., Ignee A et al. Contrast-enhanced ultrasonography with SonoVue: differentiation between benign and malignant lesions of the spleen. J Ultrasound Med 2009 28 421-434
92. Stang A, Keles H, Hentschke S et al. Differentiation of benign from malignant focal splenic lesions using sulfur hexafluoride-filled microbubble contrast-enhanced pulse-inversion sonography. Am J Roentgenol 2009 193 709-721
93. Tafuto S, Catalano O, Barba G et al. Real-time contrast-enhanced specific ultrasound in staging and follow-up of splenic lymphomas. Front Biosci 2006 11 2224-2229 (Pubitemid 43822555)
94. Neesse A, Huth J, Kunsch S et al. Contrast-enhanced ultrasound pattern of splenic metastases a retrospective study in 32 patients. Ultraschall in Med 2010 31 264-269
95. Picardi M, Soricelli A, Pane F et al. Contrast-enhanced harmonic compound US of the spleen to increase staging accuracy in patients with Hodgkin lymphoma: a prospective study. Radiology 2009 251 574-582
96. Correas J M., Claudon M, Tranquart F et al. The kidney: imaging with microbubble contrast agents. Ultrasound Q 2006 22 53-66 (Pubitemid 44510228)
97. Bertolotto M, Martegani A, Aiani L et al. Value of contrast-enhanced ultrasonography for detecting renal infarcts proven by contrast enhanced CT. A feasibility study. Eur Radiol 2008 18 376-383 (Pubitemid 351234059)
98. Bertolotto M, Catalano O. Contrast-enhanced Ultrasound: Past, Present, and Future. in: Advances in Ultrasound, An Issue of Ultrasound Clinics. Elsevier Science 2009 4 339-367
99. Blebea J, Zickler R, Volteas N et al. Duplex imaging of the renal arteries with contrast enhancement. Vasc Endovascular Surg 2003 37 429-436 (Pubitemid 37485207)
100. Tamai H, Takiguchi Y, Oka M et al. Contrast-enhanced ultrasonography in the diagnosis of solid renal tumors. J Ultrasound Med 2005 24 1635-1640 (Pubitemid 41780705)
101. Mazziotti S, Zimbaro F, Pandolfo A et al. Usefulness of contrast-enhanced ultrasonography in the diagnosis of renal pseudotumors. Abdom Imaging 2010 35 241-245
102. Ignee A, Straub B, Brix D et al. The value of contrast enhanced ultrasound (CEUS) in the characterisation of patients with renal masses. Clin Hemorheol Microcirc 2010 46 275-290
103. Quaia E, Bertolotto M, Cioffi V et al. Comparison of contrast-enhanced sonography with unenhanced sonography and contrast-enhanced CT in the diagnosis of malignancy in complex cystic renal masses. Am J Roentgenol 2008 191 1239-1249
104. Clevert D A., Minaifar N, Weckbach S et al. Multislice computed tomography versus contrast-enhanced ultrasound in evaluation of complex cystic renal masses using the Bosniak classification system. Clin Hemorheol Microcirc 2008 39 171-178 (Pubitemid 352039998)
105. Park B K., Kim B, Kim S H. et al. Assessment of cystic renal masses based on Bosniak classification: comparison of CT and contrast-enhanced US. Eur J Radiol 2007 61 310-314 (Pubitemid 46110861)
106. Ascenti G, Mazziotti S, Zimbaro G et al. Complex cystic renal masses: characterization with contrast-enhanced US. Radiology 2007 243 158-165 (Pubitemid 46579706)
107. Ignee A, Straub B, Schuessler G et al. Contrast enhanced ultrasound of renal masses. World J Radiol 2010 2 15-31
108. Wink M H., Lagerveld B W., Laguna M P. et al. Cryotherapy for renal-cell cancer: diagnosis, treatment, and contrast-enhanced ultrasonography for follow-up. J Endourol 2006 20 456-458, discussion 458 459 (Pubitemid 44182205)
109. Johnson D B., Duchene D A., Taylor G D. et al. Contrast-enhanced ultrasound evaluation of radiofrequency ablation of the kidney: reliable imaging of the thermolesion. J Endourol 2005 19 248-252 (Pubitemid 40490472)
110. Hoeffel C, Pousset M, Timsit M O. et al. Radiofrequency ablation of renal tumours: diagnostic accuracy of contrast-enhanced ultrasound for early detection of residual tumour. Eur Radiol 2010 20 1812-1821
111. Meloni M F., Bertolotto M, Alberzoni C et al. Follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: contrast-enhanced sonography versus contrast-enhanced CT or MRI. Am J Roentgenol 2008 191 1233-1238
112. Darge K. Voiding urosonography with ultrasound contrast agents for the diagnosis of vesicoureteric reflux in children. I. Procedure. Pediatr Radiol 2008 38 40-53 (Pubitemid 350164905)
113. Darge K. Voiding urosonography with US contrast agents for the diagnosis of vesicoureteric reflux in children. II. Comparison with radiological examinations. Pediatr Radiol 2008 38 54-63, quiz 126 127 (Pubitemid 350164904)
114. Darge K. Voiding urosonography with US contrast agent for the diagnosis of vesicoureteric reflux in children: an update. Pediatr Radiol 2010 40 956-962
115. Ascenti G, Zimbaro G, Mazziotti S et al. Harmonic US imaging of vesicoureteric reflux in children: usefulness of a second generation US contrast agent. Pediatr Radiol 2004 34 481-487 (Pubitemid 38787363)
116. Lebowitz R L., Olbing H, Parkkulainen K V. et al. International system of radiographic grading of vesicoureteric reflux. International Reflux Study in Children. Pediatr Radiol 1985 15 105-109 (Pubitemid 15198933)
117. Duran C, Valera A, Alguersuari A et al. Voiding urosonography: the study of the urethra is no longer a limitation of the technique. Pediatr Radiol 2009 39 124-131
118. Moschouris H, Stamatiou K, Lampropoulou E et al. Imaging of the acute scrotum: is there a place for contrast-enhanced ultrasonography? Int Braz J Urol 2009 35 692-702, discussion 702 695
119. Bilagi P, Sriprasad S, Clarke J L. et al. Clinical and ultrasound features of segmental testicular infarction: six-year experience from a single centre. Eur Radiol 2007 17 2810-2818 (Pubitemid 47603976)
120. Sriprasad S, Kooiman G G., Muir G H. et al. Acute segmental testicular infarction: differentiation from tumour using high frequency colour Doppler ultrasound. Br J Radiol 2001 74 965-967 (Pubitemid 33064645)
121. Bertolotto M, Derchi L E., Sidhu P S. et al. Acute segmental testicular infarction at contrast-enhanced ultrasound: early features and changes during follow-up. Am J Roentgenol 2011 196 834-841
122. Valentino M, Bertolotto M, Derchi L et al. Role of contrast enhanced ultrasound in acute scrotal diseases. Eur Radiol 2011 epub
123. Bhatt S, Rubens D J., Dogra V S. Sonography of benign intrascrotal lesions. Ultrasound Q 2006 22 121-136 (Pubitemid 44491554)
124. Winter T C. There is a mass in the scrotum-what does it mean? Evaluation of the scrotal mass. Ultrasound Q 2009 25 195-205
125. Lock G, Schmidt C, Helmich F et al. Early Experience With Contrast-enhanced Ultrasound in the Diagnosis of Testicular Masses: A Feasibility Study. Urology 2011 77 1049-1053
126. Shah A, Lung P F., Clarke J L. et al. Re: New ultrasound techniques for imaging of the indeterminate testicular lesion may avoid surgery completely. Clin Radiol 2010 65 496-497
127. Catalano O, Lobianco R, Sandomenico F et al. Splenic trauma: evaluation with contrast-specific sonography and a second-generation contrast medium: preliminary experience. J Ultrasound Med 2003 22 467-477 (Pubitemid 36528749)
128. Valentino M, Serra C, Zironi G et al. Blunt abdominal trauma: emergency contrast-enhanced sonography for detection of solid organ injuries. Am J Roentgenol 2006 186 1361-1367 (Pubitemid 46112574)
129. Catalano O, Aiani L, Barozzi L et al. CEUS in abdominal trauma: multi-center study. Abdom Imaging 2009 34 225-234
130. Reissig A, Gorg C, Mathis G. Transthoracic sonography in the diagnosis of pulmonary diseases: a systematic approach. Ultraschall in Med 2009 30 438-454, quiz 455 436
131. Gorg C. Transcutaneous contrast-enhanced sonography of pleural-based pulmonary lesions. Eur J Radiol 2007 64 213-221 (Pubitemid 47595425)
132. Bertolini F A., Goerg C, Mathis G. Echo contrast ultrasound in subpleural consolidations. Echo contrast ultrasound in subpleural consolidations 2008 18 (Suppl S 395) Abstract
133. Gorg C, Bert T, Gorg K. Contrast-enhanced sonography for differential diagnosis of pleurisy and focal pleural lesions of unknown cause. Chest 2005 128 3894-3899 (Pubitemid 43062651)
134. Gorg C, Bert T, Kring R et al. Transcutaneous contrast enhanced sonography of the chest for evaluation of pleural based pulmonary lesions: experience in 137 patients. Ultraschall in Med 2006 27 437-444 (Pubitemid 44690065)
135. Clevert D A., Johnson T, Michaely H et al. High-grade stenoses of the internal carotid artery: comparison of high-resolution contrast enhanced 3D MRA, duplex sonography and power Doppler imaging. Eur J Radiol 2006 60 379-386 (Pubitemid 44781404)
136. Jung E M., Kubale R, Ritter G et al. Diagnostics and characterisation of preocclusive stenoses and occlusions of the internal carotid artery with B-flow. Eur Radiol 2007 17 439-447 (Pubitemid 46140315)
137. Clevert D A., Johnson T, Jung E M. et al. Color Doppler, power Doppler and B-flow ultrasound in the assessment of ICA stenosis: Comparison with 64-MD-CT angiography. Eur Radiol 2007 17 2149-2159 (Pubitemid 47097472)
138. Wechsler L R. Ulceration and carotid artery disease. Stroke 1988 19 650-653
139. Clevert D A., Horng A, Jung E M. et al. Contrast-enhanced ultrasound versus conventional ultrasound and MS-CT in the diagnosis of abdominal aortic dissection. Clin Hemorheol Microcirc 2009 43 129-139
140. Clevert D A., Sommer W H., Zengel P et al. Imaging of carotid arterial diseases with contrast-enhanced ultrasound (CEUS). Eur J Radiol 2011 epub
141. ten Kate G L., Sijbrands E J., Staub D et al. Noninvasive imaging of the vulnerable atherosclerotic plaque. Curr Probl Cardiol 2010 35 556-591
142. Clevert D A., Sommer W H., Helck A et al. Duplex and contrast enhanced ultrasound (CEUS) in evaluation of in-stent restenosis after carotid stenting. Clin Hemorheol Microcirc 2011 in press
143. Massalha K, Goyen M, Rudofsky G. Stenosis-jet can cause a dissection of the superficial femoral artery. Vasa 1999 28 131-133 (Pubitemid 29265809)
144. Koennecke H C., Trocio S H., Mast H Jr. et al. Microemboli on transcranial Doppler in patients with spontaneous carotid artery dissection. J Neuroimaging 1997 7 217-220
145. Clevert D A., Kubisch C, Meimarakis G et al. Improved visualization of carotid-jugular arteriovenous fistula by contrast-enhanced ultrasound. Ultraschall in Med 2010 31 610-612
146. Jaff M R., Goldmakher G V., Lev M H. et al. Imaging of the carotid arteries: the role of duplex ultrasonography, magnetic resonance arteriography, and computerized tomographic arteriography. Vasc Med 2008 13 281-292
147. Coli S, Magnoni M, Sangiorgi G et al. Contrast-enhanced ultrasound imaging of intraplaque neovascularization in carotid arteries: correlation with histology and plaque echogenicity. J Am Coll Cardiol 2008 52 223-230 (Pubitemid 351915779)
148. Giannoni M F., Vicenzini E, Citone M et al. Contrast carotid ultrasound for the detection of unstable plaques with neoangiogenesis: a pilot study. Eur J Vasc Endovasc Surg 2009 37 722-727
149. Staub D, Schinkel A F., Coll B et al. Contrast-enhanced ultrasound imaging of the vasa vasorum: from early atherosclerosis to the identification of unstable plaques. JACC Cardiovasc Imaging 2010 3 761-771
150. Staub D, Patel M B., Tibrewala A et al. Vasa vasorum and plaque neovascularization on contrast-enhanced carotid ultrasound imaging correlates with cardiovascular disease and past cardiovascular events. Stroke 2010 41 41-47
151. Catalano O, Lobianco R, Cusati B et al. Contrast-enhanced sonography for diagnosis of ruptured abdominal aortic aneurysm. Am J Roentgenol 2005 184 423-427 (Pubitemid 46657244)
152. Spittell P C., Spittell J A., Joyce J W. et al. Clinical features and differential diagnosis of aortic dissection: experience with 236 cases (1980 through 1990). Mayo Clin Proc 1993 68 642-651 (Pubitemid 23193889)
153. Clevert D A., Rupp N Jr., Reiser M et al. Improved diagnosis of vascular dissection by ultrasound B-flow: a comparison with color-coded Doppler and power Doppler sonography. Eur Radiol 2005 15 342-347
154. Clevert D A., Stickel M, Johnson T et al. Imaging of aortic abnormalities with contrast-enhanced ultrasound. A pictorial comparison with CT. Eur Radiol 2007 17 2991-3000 (Pubitemid 47603998)
155. Clevert D A., Stickel M, Kopp R et al. Contrast-enhanced ultrasound versus CT and operative findings in evaluation of renal vein aneurysm with AV fistula. Clin Hemorheol Microcirc 2008 39 147-154 (Pubitemid 352039992)
156. Arrive L, Correas J M., Leseche G et al. Inflammatory aneurysms of the abdominal aorta: CT findings. Am J Roentgenol 1995 165 1481-1484
157. Pennell R C., Hollier L H., Lie J T. et al. Inflammatory abdominal aortic aneurysms: a thirty-year review. J Vasc Surg 1985 2 859-869 (Pubitemid 16170951)
158. Walker D I., Bloor K, Williams G et al. Inflammatory aneurysms of the abdominal aorta. Br J Surg 1972 59 609-614
159. Witz M, Korzets Z. Inflammatory abdominal aortic aneurysms. Isr Med Assoc J 2005 7 385-387 (Pubitemid 40862043)
160. Crawford J L., Stowe C L., Safi H J. et al. Inflammatory aneurysms of the aorta. J Vasc Surg 1985 2 113-124 (Pubitemid 15054136)
161. Clevert D A., Schick K, Chen M H. et al. Role of contrast enhanced ultrasound in detection of abdominal aortic abnormalities in comparison with
162. Thurnher S, Cejna M. Imaging of aortic stent-grafts and endoleaks. Radiol Clin North Am 2002 40 799-833 (Pubitemid 34831577)
163. Clevert D A., Minaifar N, Weckbach S et al. Color duplex ultrasound and contrast-enhanced ultrasound in comparison to MS-CT in the detection of endoleak following endovascular aneurysm repair. Clin Hemorheol Microcirc 2008 39 121-132 (Pubitemid 352039990)
164. dAudiffret A, Desgranges P, Kobeiter D H. et al. Follow-up evaluation of endoluminally treated abdominal aortic aneurysms with duplex ultrasonography: validation with computed tomography. J Vasc Surg 2001 33 42-50 (Pubitemid 32109605)
165. Sommer W H., Hoffmann R T., Becker C R. et al. Comparison of time-resolved CT-angiography, contrast-enhanced ultrasound and digital subtraction angiography in a patient with a small type II endoleak after endovascular aneurysm repair. Clin Hemorheol Microcirc 2010 45 19-25
166. McLafferty R B., McCrary B S., Mattos M A. et al. The use of color-flow duplex scan for the detection of endoleaks. J Vasc Surg 2002 36 100-104 (Pubitemid 41122896)
167. Greenfield A L., Halpern E J., Bonn J et al. Application of duplex US for characterization of endoleaks in abdominal aortic stent-grafts: report of five cases. Radiology 2002 225 845-851 (Pubitemid 35387126)
168. Jung E M., Rennert J, Fellner C et al. Detection and characterization of endoleaks following endovascular treatment of abdominal aortic aneurysms using contrast harmonic imaging (CHI) with quantitative perfusion analysis (TIC) compared to CT angiography (CTA). Ultraschall in Med 2010 31 564-570
169. Pfister K, Rennert J, Uller W et al. Contrast harmonic imaging ultrasound and perfusion imaging for surveillance after endovascular abdominal aneurysm repair regarding detection and characterization of suspected endoleaks. Clin Hemorheol Microcirc 2009 43 119-128
170. Ten Bosch J A., Rouwet E V., Peters C T. et al. Contrast-enhanced ultrasound versus computed tomographic angiography for surveillance of endovascular abdominal aortic aneurysm repair. J Vasc Interv Radiol 2010 21 638-643
171. Seidel G, Meairs S. Ultrasound contrast agents in ischemic stroke. Cerebrovasc Dis 2009 27 (Suppl 2) 25-39
172. Seidel G, Kaps M. Harmonic imaging of the vertebrobasilar system. Stroke 1997 28 1610-1613 (Pubitemid 27349691)
173. Postert T, Braun B, Meves S et al. Contrast-enhanced transcranial color-coded sonography in acute hemispheric brain infarction. Stroke 1999 30 1819-1826 (Pubitemid 29411821)
174. Droste D W., Jurgens R, Weber S et al. Benefit of echocontrast-enhanced transcranial color-coded duplex ultrasound in the assessment of intracranial collateral pathways. Stroke 2000 31 920-923 (Pubitemid 30198439)
175. Seidel G, Cangur H, Meyer-Wiethe K et al. On the ability of ultrasound parametric perfusion imaging to predict the area of infarction in acute ischemic stroke. Ultraschall in Med 2006 27 543-548 (Pubitemid 46089116)
176. Eyding J, Krogias C, Schollhammer M et al. Contrast-enhanced ultrasonic parametric perfusion imaging detects dysfunctional tissue at risk in acute MCA stroke. J Cereb Blood Flow Metab 2006 26 576-582
177. Krogias C, Hennebohl C, Geier B et al. Transcranial ultrasound perfusion imaging and perfusion-MRI a pilot study on the evaluation of cerebral perfusion in severe carotid artery stenosis. Ultrasound Med Biol 2010 36 1973-1980
178. Krogias C, Meves S H., Hansen C et al. Ultrasound Perfusion Imaging of the Brain-Routine and Novel Applications: Uncommon Cases and Review of the Literature. J Neuroimaging 2010 21 255-258
179. Eggers J, Konig I R., Koch B et al. Sonothrombolysis with transcranial color-coded sonography and recombinant tissue-type plasminogen activator in acute middle cerebral artery main stem occlusion: results from a randomized study. Stroke 2008 39 1470-1475
180. FitzGerald O, Bresnihan B. Synovial membrane cellularity and vascularity. Ann Rheum Dis 1995 54 511-515
181. Klauser A, Frauscher F, Schirmer M. Value of contrast-enhanced power Doppler ultrasonography (US) of the metacarpophalangeal joints on rheumatoid arthritis. Eur Radiol 2004 14 545-546, author reply 547 548
182. Klauser A S., Peetrons P. Developments in musculoskeletal ultrasound and clinical applications. Skeletal Radiol 2010 39 1061-1071
183. De Zordo T, Mlekusch S P., Feuchtner G M. et al. Value of contrast-enhanced ultrasound in rheumatoid arthritis. Eur J Radiol 2007 64 222-230 (Pubitemid 47588751)
184. Taylor P C. The value of sensitive imaging modalities in rheumatoid arthritis. Arthritis Res Ther 2003 5 210-213 (Pubitemid 37139035)
185. Hermann K G., Backhaus M, Schneider U et al. Rheumatoid arthritis of the shoulder joint: comparison of conventional radiography, ultrasound, and dynamic contrast-enhanced magnetic resonance imaging. Arthritis Rheum 2003 48 3338-3349 (Pubitemid 37531900)
186. Klauser A, Frauscher F, Schirmer M et al. The value of contrast-enhanced color Doppler ultrasound in the detection of vascularization of finger joints in patients with rheumatoid arthritis. Arthritis Rheum 2002 46 647-653 (Pubitemid 34214247)
187. Doria A S., Kiss M H., Lotito A P. et al. Juvenile rheumatoid arthritis of the knee: evaluation with contrast-enhanced color Doppler ultrasound. Pediatr Radiol 2001 31 524-531 (Pubitemid 32611405)
188. Magarelli N, Guglielmi G, Di Matteo L et al. Diagnostic utility of an echo-contrast agent in patients with synovitis using power Doppler ultrasound: a preliminary study with comparison to contrast-enhanced MRI. Eur Radiol 2001 11 1039-1046 (Pubitemid 32755571)
189. Klauser A, Halpern E J., Frauscher F et al. Inflammatory low back pain: high negative predictive value of contrast-enhanced color Doppler ultrasound in the detection of inflamed sacroiliac joints. Arthritis Rheum 2005 53 440-444 (Pubitemid 40799885)
190. Ostergaard M, Hansen M, Stoltenberg M et al. Magnetic resonance imaging-determined synovial membrane volume as a marker of disease activity and a predictor of progressive joint destruction in the wrists of patients with rheumatoid arthritis. Arthritis Rheum 1999 42 918-929 (Pubitemid 29215002)
191. Klauser A, Demharter J, De Marchi A et al. Contrast enhanced gray-scale sonography in assessment of joint vascularity in rheumatoid arthritis: results from the IACUS study group. Eur Radiol 2005 15 2404-2410 (Pubitemid 43153839)
192. Schueller-Weidekamm C, Krestan C, Schueller G et al. Power Doppler sonography and pulse-inversion harmonic imaging in evaluation of rheumatoid arthritis synovitis. Am J Roentgenol 2007 188 504-508 (Pubitemid 46167753)
193. Klauser A S., Franz M, Arora R et al. Detection of vascularity in wrist tenosynovitis: power doppler ultrasound compared with contrast-enhanced grey-scale ultrasound. Arthritis Res Ther 2010 12 R209
194. Wamser G, Bohndorf K, Vollert K et al. Power Doppler sonography with and without echo-enhancing contrast agent and contrast-enhanced MRI for the evaluation of rheumatoid arthritis of the shoulder joint: differentiation between synovitis and joint effusion. Skeletal Radiol 2003 32 351-359 (Pubitemid 36790240)
195. Carotti M, Salaffi F, Manganelli P et al. Power Doppler sonography in the assessment of synovial tissue of the knee joint in rheumatoid arthritis: a preliminary experience. Ann Rheum Dis 2002 61 877-882
196. Hau M, Kneitz C, Tony H P. et al. High resolution ultrasound detects a decrease in pannus vascularisation of small finger joints in patients with rheumatoid arthritis receiving treatment with soluble tumour necrosis factor alpha receptor (etanercept). Ann Rheum Dis 2002 61 55-58 (Pubitemid 34074841)
197. Song I H., Althoff C E., Hermann K G. et al. Contrast-enhanced ultrasound in monitoring the efficacy of a bradykinin receptor 2 antagonist in painful knee osteoarthritis compared with MRI. Ann Rheum Dis 2009 68 75-83
198. Qvistgaard E, Kristoffersen H, Terslev L et al. Guidance by ultrasound of intra-articular injections in the knee and hip joints. Osteoarthritis Cartilage 2001 9 512-517 (Pubitemid 32842630)
199. Qvistgaard E, Rogind H, Torp-Pedersen S et al. Quantitative ultrasonography in rheumatoid arthritis: evaluation of inflammation by Doppler technique. Ann Rheum Dis 2001 60 690-693 (Pubitemid 32588373)
200. Lanzani C, Savasi V, Leone F P. et al. Two-dimensional HyCoSy with contrast tuned imaging technology and a second-generation contrast media for the assessment of tubal patency in an infertility program. Fertil Steril 2009 92 1158-1161
201. Boudghene F P., Bazot M, Robert Y et al. Assessment of Fallopian tube patency by HyCoSy: comparison of a positive contrast agent with saline solution. Ultrasound Obstet Gynecol 2001 18 525-530
202. Tamasi F, Weidner A, Domokos N et al. ECHOVIST-200 enhanced hystero-sonography: a new technique in the assessment of infertility. Eur J Obstet Gynecol Reprod Biol 2005 121 186-190 (Pubitemid 41074091)
203. Foschi F G., Piscaglia F, Pompili M et al. Real-time contrast-enhanced ultrasound - a new simple tool for detection of peritoneal-pleural communications in hepatic hydrothorax. Ultraschall in Med 2008 29 538-542
204. Tamano M, Hashimoto T, Kojima K et al. Diagnosis of hepatic hydrothorax using contrast-enhanced ultrasonography with intraperitoneal injection of Sonazoid. J Gastroenterol Hepatol 2010 25 383-386
205. Ignee A, Baum U, Schuessler G et al. Contrast-enhanced ultrasound-guided percutaneous cholangiography and cholangiodrainage (CEUS-PTCD). Endoscopy 2009 41 725-726
206. Mao R, Xu E J., Li K et al. Usefulness of contrast-enhanced ultrasound in the diagnosis of biliary leakage following T-tube removal. J Clin Ultrasound 2009 38 38-40
207. Zuber-Jerger I, Endlicher E, Scholmerich J et al. Endoscopic retrograde cholangiography with contrast ultrasonography. Endoscopy 2008 40 (Suppl 2) E202
208. Zengel P, Berghaus A, Weiler C et al. Intraductally applied contrast-enhanced ultrasound (IA-CEUS) for evaluating obstructive disease and secretory dysfunction of the salivary glands. Eur Radiol 2011 21 1339-1348
209. Volkmer B G., Nesslauer T, Kufer R et al. [Diagnosis of vesico-intestinal fistulas by contrast medium enhanced 3-D ultrasound]. Ultraschall in Med 2001 22 81-86 (Pubitemid 32433673)
210. Chew S S., Yang J L., Newstead G L. et al. Anal fistula: Levovist-enhanced endoanal ultrasound: a pilot study. Dis Colon Rectum 2003 46 377-384 (Pubitemid 36331658)
211. Moritz J D., Ludwig A, Oestmann J W. Contrast-enhanced color Doppler sonography for evaluation of enlarged cervical lymph nodes in head and neck tumors. Am J Roentgenol 2000 174 1279-1284 (Pubitemid 30261774)
212. Benzel W, Zenk J, Winter M et al. [Color Doppler ultrasound studies of benign and malignant lymph nodes]. HNO 1996 44 666-671 (Pubitemid 27019445)
213. Schmid-Wendtner M H., Partscht K, Korting H C. et al. Improved differentiation of benign and malignant lymphadenopathy in patients with cutaneous melanoma by contrast-enhanced color Doppler sonography. Arch Dermatol 2002 138 491-497 (Pubitemid 34290026)
214. Schulte-Altedorneburg G, Demharter J, Linne R et al. Does ultrasound contrast agent improve the diagnostic value of colour and power Doppler sonography in superficial lymph node enlargement? Eur J Radiol 2003 48 252-257 (Pubitemid 37491062)
215. Schmid-Wendtner M H., Dill-Muller D, Baumert J et al. Lymph node metastases in patients with cutaneous melanoma: improvements in diagnosis by signal-enhanced color Doppler sonography. Melanoma Res 2004 14 269-276 (Pubitemid 39159139)
216. Zenk J, Bozzato A, Steinhart H et al. Metastatic and inflammatory cervical lymph nodes as analyzed by contrast-enhanced color-coded Doppler ultrasonography: quantitative dynamic perfusion patterns and histopathologic correlation. Ann Otol Rhinol Laryngol 2005 114 43-47 (Pubitemid 40116513)
217. Stoeckelhuber B M., Wiesmann M, Berg S A. et al. [Sonography of enlarged lymph nodes: Pathogenetic categorization using contrast enhanced power Doppler sonography]. Hautarzt 2006 57 610-617
218. Weskott H P. Emerging roles for contrast-enhanced ultrasound. Clin Hemorheol Microcirc 2008 40 51-71
219. Steppan I, Reimer D, Muller-Holzner E et al. Breast cancer in women: evaluation of benign and malignant axillary lymph nodes with contrast-enhanced ultrasound. Ultraschall in Med 2010 31 63-67
220. Ouyang Q, Chen L, Zhao H et al. Detecting metastasis of lymph nodes and predicting aggressiveness in patients with breast carcinomas. J Ultrasound Med 2010 29 343-352
221. Stramare R, Scagliori E, Mannucci M et al. The role of contrast-enhanced gray-scale ultrasonography in the differential diagnosis of superficial lymph nodes. Ultrasound Q 2010 26 45-51
222. Yu M, Liu Q, Song H P. et al. Clinical application of contrast-enhanced ultrasonography in diagnosis of superficial lymphadenopathy. J Ultrasound Med 2010 29 735-740
223. Rubaltelli L, Beltrame V, Tregnaghi A et al. Contrast-enhanced ultrasound for characterizing lymph nodes with focal cortical thickening in patients with cutaneous melanoma. Am J Roentgenol 2011 196 W8-W12
224. Hocke M, Menges M, Topalidis T et al. Contrast-enhanced endoscopic ultrasound in discrimination between benign and malignant mediastinal and abdominal lymph nodes. J Cancer Res Clin Oncol 2008 134 473-480 (Pubitemid 351322383)
225. Nakase K, Yamamoto K, Hiasa A et al. Contrast-enhanced ultrasound examination of lymph nodes in different types of lymphoma. Cancer Detect Prev 2006 30 188-191 (Pubitemid 43766231)
226. Rue Nielsen K, Klyver H, Hougaard Chakera A et al. Sentinel node detection in melanomas using contrast-enhanced ultrasound. Acta Radiol 2009 50 412-417
227. Wang Y, Wang W, Li J et al. Gray-scale contrast-enhanced ultrasonography of sentinel lymph nodes in a metastatic breast cancer model. Acad Radiol 2009 16 957-962
228. Omoto K, Matsunaga H, Take N et al. Sentinel node detection method using contrast-enhanced ultrasonography with sonazoid in breast cancer: preliminary clinical study. Ultrasound Med Biol 2009 35 1249-1256
229. Sever A, Jones S, Cox K et al. Preoperative localization of sentinel lymph nodes using intradermal microbubbles and contrast-enhanced ultrasonography in patients with breast cancer. Br J Surg 2009 96 1295-1299
230. Nielsen K R. Studies on radionuclide imaging and contrast ultrasound for sentinel node diagnostics in breast cancer and melanoma. Dan Med Bull 2011 58 B4225
231. Sever A R., Mills P, Jones S E. et al. Preoperative sentinel node identification with ultrasound using microbubbles in patients with breast cancer. Am J Roentgenol 2010 196 251-256
232. Tozer G M. Measuring tumour vascular response to antivascular and antiangiogenic drugs. Br J Radiol 2003 76 Spec No 1 S23-S35 (Pubitemid 39530313)
233. Eisenhauer E A., Therasse P, Bogaerts J et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009 45 228-247
234. Zhu A X., Holalkere N S., Muzikansky A et al. Early antiangiogenic activity of bevacizumab evaluated by computed tomography perfusion scan in patients with advanced hepatocellular carcinoma. Oncologist 2008 13 120-125 (Pubitemid 351342575)
235. Peronneau P, Lassau N, Leguerney I et al. Contrast ultrasonography: necessity of linear data processing for the quantification of tumor vascularization. Ultraschall in Med 2010 31 370-378
236. Averkiou M, Lampaskis M, Kyriakopoulou K et al. Quantification of tumor microvascularity with respiratory gated contrast enhanced ultrasound for monitoring therapy. Ultrasound Med Biol 2010 36 68-77
237. Williams R, Hudson J M., Lloyd B A. et al. Dynamic Microbubble Contrast-enhanced US to Measure Tumor Response to Targeted Therapy: A Proposed Clinical Protocol with Results from Renal Cell Carcinoma Patients Receiving Antiangiogenic Therapy. Radiology 2011 260 581-590
238. Lassau N, Lamuraglia M, Vanel D et al. Doppler US with perfusion software and contrast medium injection in the early evaluation of isolated limb perfusion of limb sarcomas: prospective study of 49 cases. Ann Oncol 2005 16 1054-1060 (Pubitemid 41418305)
239. Cosgrove D, Lassau N. Imaging of perfusion using ultrasound. Eur J Nucl Med Mol Imaging 2010 37 (Suppl 1) S65-S85
240. Lamuraglia M, Escudier B, Chami L et al. To predict progression-free survival and overall survival in metastatic renal cancer treated with sorafenib: pilot study using dynamic contrast-enhanced Doppler ultrasound. Eur J Cancer 2006 42 2472-2479 (Pubitemid 44442955)
241. Lassau N, Lamuraglia M, Chami L et al. Gastrointestinal stromal tumors treated with imatinib: monitoring response with contrast-enhanced sonography. Am J Roentgenol 2006 187 1267-1273 (Pubitemid 44630831)
242. De Giorgi U, Aliberti C, Benea G et al. Effect of angiosonography to monitor response during imatinib treatment in patients with metastatic gastrointestinal stromal tumors. Clin Cancer Res 2005 11 6171-6176 (Pubitemid 41262944)
243. Escudier B, Lassau N, Angevin E et al. Phase I trial of sorafenib in combination with IFN alpha-2a in patients with unresectable and/or metastatic renal cell carcinoma or malignant melanoma. Clin Cancer Res 2007 13 1801-1809 (Pubitemid 46952949)
244. Lassau N, Koscielny S, Albiges L et al. Metastatic renal cell carcinoma treated with sunitinib: early evaluation of treatment response using dynamic contrast-enhanced ultrasonography. Clin Cancer Res 2010 16 1216-1225
245. Lassau N, Chami L, Koscielny S et al. Quantitative functional imaging by Dynamic Contrast Enhanced Ultrasonography (DCE-US) in GIST patients treated with masatinib. Invest New Drugs 2010 epub
246. Lassau N, Koscielny S, Chami L et al. Advanced hepatocellular carcinoma: early evaluation of response to bevacizumab therapy at dynamic contrast-enhanced US with quantification preliminary results. Radiology 2011 258 291-300
247. Lassau N, Chami L, Chebil M et al. Dynamic contrast-enhanced ultrasonography (DCE-US) and anti-angiogenic treatments. Discov Med 2011 11 18-24
248. Casali P G., Blay J Y., Experts ECECPo. Gastrointestinal stromal tumours: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010 (Suppl 5) v98-v102
249. Cosgrove D O., Bamber J C., Davey J B. et al. Color Doppler signals from breast tumors. Work in progress. Radiology 1990 176 175-180 (Pubitemid 20208132)
250. Sorelli P G., Cosgrove D O., Svensson W E. et al. Can contrast-enhanced sonography distinguish benign from malignant breast masses? J Clin Ultrasound 2010 38 177-181
251. Balleyguier C, Opolon P, Mathieu M C. et al. New potential and applications of contrast-enhanced ultrasound of the breast: Own investigations and review of the literature. Eur J Radiol 2009 69 14-23
252. Liu H, Jiang Y X., Liu J B. et al. Evaluation of breast lesions with contrast-enhanced ultrasound using the microvascular imaging technique: initial observations. Breast 2008 17 532-539
253. Caproni N, Marchisio F, Pecchi A et al. Contrast-enhanced ultrasound in the characterisation of breast masses: utility of quantitative analysis in comparison with MRI. Eur Radiol 2009 20 1384-1395
254. Friedrich-Rust M, Glasemann T, Polta A et al. Differentiation between Benign and Malignant Adrenal Mass using Contrast-Enhanced Ultrasound. Ultraschall in Med 2011 epub
255. Dietrich C F., Ignee A, Barreiros A P. et al. Contrast-enhanced ultrasound for imaging of adrenal masses. Ultraschall in Med 2010 31 163-168
256. Testa A C., Ferrandina G, Fruscella E et al. The use of contrasted transvaginal sonography in the diagnosis of gynecologic diseases: a preliminary study. J Ultrasound Med 2005 24 1267-1278 (Pubitemid 41243618)
257. Lieng M, Qvigstad E, Dahl G F. et al. Flow differences between endometrial polyps and cancer: a prospective study using intravenous contrast-enhanced transvaginal color flow Doppler and three-dimensional power Doppler ultrasound. Ultrasound Obstet Gynecol 2008 32 935-940
258. Marret H, Sauget S, Giraudeau B et al. Contrast-enhanced sonography helps in discrimination of benign from malignant adnexal masses. J Ultrasound Med 2004 23 1629-1639, quiz 1641 1642 (Pubitemid 39586868)
259. Orden M R., Jurvelin J S., Kirkinen P P. Kinetics of a US contrast agent in benign and malignant adnexal tumors. Radiology 2003 226 405-410 (Pubitemid 36313427)
260. Testa A C., Timmerman D, Exacoustos C et al. The role of CnTI-SonoVue in the diagnosis of ovarian masses with papillary projections: a preliminary study. Ultrasound Obstet Gynecol 2007 29 512-516 (Pubitemid 46826551)
261. Caruso G, Salvaggio G, Campisi A et al. Bladder tumor staging: comparison of contrast-enhanced and gray-scale ultrasound. Am J Roentgenol 2010 194 151-156
262. Drudi F M., Cantisani V, Liberatore M et al. Role of low-mechanical index CEUS in the differentiation between low and high grade bladder carcinoma: a pilot study. Ultraschall in Med 2010 31 589-595
263. Nicolau C, Bunesch L, Sebastia C et al. Diagnosis of bladder cancer: contrast-enhanced ultrasound. Abdom Imaging 2010 35 494-503
264. Lefevre F, Correas J M., Briancon S et al. Contrast-enhanced sonography of the renal transplant using triggered pulse-inversion imaging: preliminary results. Ultrasound Med Biol 2002 28 303-314 (Pubitemid 34308910)
265. Mitterberger M J., Aigner F, Horninger W et al. Comparative efficiency of contrast-enhanced colour Doppler ultrasound targeted versus systematic biopsy for prostate cancer detection. Eur Radiol 2010 20 2791-2796
266. Wink M, Frauscher F, Cosgrove D et al. Contrast-enhanced ultrasound and prostate cancer, a multicentre European research coordination project. Eur Urol 2008 54 982-992
267. Aigner F, Pallwein L, Mitterberger M et al. Contrast-enhanced ultrasonography using cadence-contrast pulse sequencing technology for targeted biopsy of the prostate. BJU Int 2009 103 458-463
268. Sano F, Terao H, Kawahara T et al. Contrast-enhanced ultrasonography of the prostate: various imaging findings that indicate prostate cancer. BJU Int 2010 107 1404-1410
269. Strazdina A, Krumina G, Sperga M. The value and limitations of contrast-enhanced ultrasound in detection of prostate cancer. Anticancer Res 2011 31 1421-1426
270. Davis P M., Gloviczki P, Cherry K J. et al. Aorto-caval and ilio-iliac arteriovenous fistulae. Am J Surg 1998 176 115-118 (Pubitemid 28420423)
271. Gardiner M D., Nanchahal J Jr. Strategies to ensure success of microvascular free tissue transfer. J Plast Reconstr Aesthet Surg 2010 63 e665-673
272. Prantl L, Pfister K, Kubale R et al. Value of high resolution ultrasound and contrast enhanced US pulse inversion imaging for the evaluation of the vascular integrity of free-flap grafts. Clin Hemorheol Microcirc 2007 36 203-216 (Pubitemid 46866634)
273. Prantl L, Schmitt S, Geis S et al. Contrast harmonic ultrasound and indocyanine-green fluorescence video angiography for evaluation of dermal and subdermal microcirculation in free parascapular flaps. Clin Hemorheol Microcirc 2008 38 105-118
274. Prantl L, Schreml S, Walter M et al. Evaluation of microcirculation of free flaps of the lower leg by contrast harmonic imaging (CHI) with time intensity curve (TIC) analysis. Clin Hemorheol Microcirc 2008 39 343-350 (Pubitemid 352040015)
275. Lamby P, Prantl L, Schreml S et al. Improvements in high resolution ultrasound for postoperative investigation of capillary microperfusion after free tissue transfer. Clin Hemorheol Microcirc 2009 43 35-49
276. Prantl L, Fellner C, Jung M E. Evaluation of free flap perfusion with dynamic contrast-enhanced magnetic resonance imaging. Plast Reconstr Surg 2010 126 100e-101e
277. Jung E M., Prantl L, Schreyer A G. et al. New perfusion imaging of tissue transplants with Contrast Harmonic Ultrasound Imaging (CHI) and Magnetic Resonance Imaging (MRI) in comparison with laser-induced Indocyanine Green (ICG) fluorescence angiography. Clin Hemorheol Microcirc 2009 43 19-33
278. Geis S, Prantl L, Gehmert S et al. TTP (time to PEAK) and RBV (regional blood volume) as valuable parameters to detect early flap failure. Clin Hemorheol Microcirc 2011 47 1-14
279. Fellner C, Jung E M., Prantl L. Dynamic contrast-enhanced MRI as a valuable non-invasive tool to evaluate tissue perfusion of free flaps: Preliminary results. Clin Hemorheol Microcirc 2010 46 77-87
280. Lamby P, Prantl L, Fellner C et al. Post-operative monitoring of tissue transfers: Advantages using contrast enhanced ultrasound (CEUS) and contrast enhanced MRI (ceMRI) with dynamic perfusion analysis? Clin Hemorheol Microcirc 2011 in press
281. ESUR guidelines on contrast media. http://wwwesurorg/Contrast- media510html#c270 [accessed June 2011]
282. Thomsen H S. ESUR guideline: gadolinium-based contrast media and nephrogenic systemic fibrosis. Eur Radiol 2007 17 2692-2696